RBMS1 identified as a key factor in multiple myeloma malignancy and macrophage polarization
RBMS1 enhances PDPK1 mRNA stability, promoting multiple myeloma cell proliferation and M2 macrophage polarization.
Asset / Drug
Drug and asset intelligence for RBMS1 with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.